Le Lézard
Classified in: Mining industry, Covid-19 virus
Subjects: NPT, POL

New Jersey Bill Supporting Annual Funding for New Jersey Manufacturing Extension Program, Inc. (NJMEP) Passes both State Assembly and Senate


CEDAR KNOLLS, N.J., Oct. 30, 2020 /PRNewswire/ -- During yesterday's legislative session, S1957 and A3756 received 100% support from the New Jersey State Senate and General Assembly.  The Bill establishes a permanent new source of funding of up to $1.5 million for the New Jersey Manufacturing Extension Program, Inc., (NJMEP).

The bill that now needs to be signed by Governor Phil Murphy, calls for $1.5 million to be invested annually in NJMEP to help stimulate job growth ? especially in underserved communities, including to industries re-engineering to make PPEs and to help domesticate the New Jersey supply chain in the wake of the COVID-19 pandemic activities.  The program will be guided by NJMEP, which plans to also use these funds to open a southern New Jersey operation to make sure this training and jobs program is equally effective throughout the state.

NJMEP's extensive engagement and collaboration with the state's manufacturers, educators, and government leaders - and the resulting economic impacts and Return on Investment were key in obtaining the state funding.  NJMEP has a history of high marks within the national program's performance metrics, and in the first six months of 2020, the organization set records as the number one MEP center in the country. More significantly, the Center has helped its clients collectively achieve more than $4.63 billion in economic impact in New Jersey. This goes along with a consistent 15:1 ROI that grew to 30:1 during the past 9-months of work during the Pandemic.

"New Jersey's economy was built on the strength of our manufacturing industry and this bill gives NJMEP a targeted boost to help accelerate job growth, drive business, and help manufacturers compete in the global economy," said John W. Kennedy, Ph.D, CEO, NJMEP. "NJMEP will help New Jersey manufacturers stay ahead of the curve, and help manufacturers create jobs here in the Garden State," adds Kennedy.

"We are grateful for the Senators and Assembly Members, including those on the Legislative Manufacturing Caucus, for coming together in a bi-partisan way to approve the passing of the bill allowing NJMEP to receive annual funding," continues Kennedy.  "This bill is transformational for our state.  It will help ensure that products and critical Industry innovation will continue to be made in right here in New Jersey and that we can continue providing professional development programs to New Jersey residents, especially those in underserved communities. We look forward to Governor Murphy signing this historic bill into law very soon," adds Kennedy.

About NJMEP: NJMEP is a private, not?for-profit organization that improves the profitability and competitiveness of New Jersey's manufacturers. Backed by the National Institute of Standards and Technology (NIST), NJMEP enables organizations to enhance their productivity and efficiencies, reduce costs, and improve employee performance.

For more than 20 years, NJMEP has used its extensive network of connections and proven track record of success to help manufacturers adapt to the latest innovative technologies and best practices to realize more than $4.63 billion in value. Our services are categorized into the following three areas: Operational Excellence, Innovation and Growth Strategies, and Workforce Development. NJMEP also has a signature philanthropic program, Manufacturing Cares, which is designed to provide a platform for manufacturers to give back to the community by pooling efforts to increase our impact.

 

SOURCE New Jersey Manufacturing Extension Program


These press releases may also interest you

at 22:00
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating TezspireŽ (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: